Q7: March 2019 PLAB 1 Exam Style Question
From 2024 PLAB will be replaced by the UKMLA exam. Check out our services for the appropriate exam.
A 60-year-old woman attends the outpatient clinic accompanied by her daughter. She describes a year-long history of skin changes involving her hands and lower arms, characterized by tightening, and difficulty in making a fist. She mentions episodes of her fingers turning pale, blue, and then red, particularly during cold weather. Additionally, she has been experiencing dysphagia affecting both solids and liquids for the past six months. She has no significant past medical history and denies any history of smoking, alcohol consumption, or illicit drug use. On examination, the skin on her hands and lower arms is visibly taut and shiny. Her facial skin also appears slightly tight.
Which autoantibody is most likely to be present in this patient based on her clinical presentation?
A. Anti-mitochondrial antibody (AMA)
B. Anti-cyclic citrullinated peptide (Anti-CCP)
C. Anti-double-stranded DNA (Anti-dsDNA)
D. Anti-centromere antibody
E. Anti-topoisomerase I (Anti-Scl-70)
Explanation is given below
Try Before You Buy
Experience the difference yourself
We're so confident in our content—backed by over a decade of experience—that we want you to try it free.
70+ Sample Questions
Select Study Essential Topics
Limited AI Tutor Access
Answer: D. Anti-centromere antibody
Explanation
Diagnosis:
The symptoms described by the patient, which include skin tightening in the hands and arms, episodes of Raynaud's phenomenon, and dysphagia, strongly point towards limited cutaneous systemic sclerosis, also known as CREST syndrome (Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasias).
A. Anti-mitochondrial antibody (AMA):
This antibody is linked to primary biliary cirrhosis (PBC), an autoimmune liver disease. It's not commonly associated with the symptoms described here.
B. Anti-cyclic citrullinated peptide (Anti-CCP):
These antibodies are typically associated with rheumatoid arthritis (RA), which primarily affects joints and does not manifest with the skin changes seen here.
C. Anti-double-stranded DNA (Anti-dsDNA):
This antibody is most often found in systemic lupus erythematosus (SLE), a condition that can have a wide range of symptoms including joint pain, fever, fatigue, and malar rash, but not the skin tightening described in this case.
D. Anti-centromere antibody:
Limited cutaneous systemic sclerosis is highly associated with the presence of anti-centromere antibodies. This option is the most consistent with the patient's clinical presentation, making it the correct answer.
E. Anti-topoisomerase I (Anti-Scl-70):
This antibody is commonly seen in diffuse systemic sclerosis, which would involve skin changes extending to the trunk and proximal extremities, unlike the distal skin changes described in this patient's case.
Summary:
In this case, the patient’s symptoms and clinical presentation are indicative of limited cutaneous systemic sclerosis. Anti-centromere antibodies are highly correlated with this form of the disease, making it the most likely diagnosis.
Other answer options are heavily discussed in our platform. Sign up for our PLAB or UKMLA services and get access to all the necessary materials required to pass the exam.
The above question is a high-yield exam PLAB 1 / UKMLA question-style question. At MedRevisions, We provide questions and not only explain the correct answer, we also explain the wrong answer so you will have a comprehensive understanding of the concepts that are commonly tested in the exam. On top of that, we also provide you PLAB 1 / UKMLA exam curated notes at no additional cost.
To discuss to more PLAB or UK-MLA exam style questions, Join: PLAB 1 /UKMLA exam study group
At MedRevisions, we strive to provide the most up-to-date content available for the PLAB and UKMLA exams. We constantly add exam-style questions reflecting the high-yield concepts seen in recent exam trends and update our content to align with the latest NICE/CKS guidelines to help doctors prepare to pass the PLAB or UKMLA with confidence.
What we provide and why MedRevisions is the best question bank and Study material available for the PLAB or UKMLA exam:
5000+ Questions: Covering every inch of the MLA Content Map.
Integrated Notes: Tailored Study Notes: Our comprehensive notes cover all key PLAB 1/UKMLA topics with clear explanations and highlighted take-home points. They’re designed to complement the question bank and reinforce your knowledge, making your revision as efficient as possible. Every important guideline, investigation, and management point you need to know is distilled for quick understanding.
Smart Analytics: We visualize your progress, showing you exactly which AoCPs (Areas of Clinical Practice) are your strongest and weakest.
MedRevisions AI Professor for PLAB and UKMLA: Imagine having a medical professor sitting next to you 24/7. A professor who knows exactly what you are studying, understands your weak spots, never gets tired of your questions, and has instant access to over 5,000+ exam-style questions and verified study notes. Read more about how to use MedRevisions AI Professor
Realistic Exam Simulation: Our question bank closely mirrors recent PLAB/UKMLA exams in style and difficulty. You’ll go into the exam feeling as if you’ve seen it all before, familiar with the question formats and level of complexity in each topic area.
Always Updated: Content is continuously aligned with the latest MLA content map and UK medical guidelines – we update promptly after each exam and after any guideline change. This means you’re always revising with relevant, up-to-date material, and never studying outdated advice or superseded protocols.
Proven Success: We have a strong track record of helping candidates excel in the PLAB and UKMLA exams on their first attempt. Our users’ successes are a testament to the effectiveness of our approach – and your success is our success.
30+ Full Mock Exams: Hone your exam technique with our library of full-length mock exams. We offer over 30 realistic mocks that simulate the actual PLAB 1, so you can practice under exam conditions. Even better, you can reset and retake these mocks as many times as you want – each attempt will bring a new mix of questions, giving you virtually endless practice and helping build your stamina for the real exam.
Study Essential Mode: Use our specialised high-yield Study Essential Mode to focus on the ~1,800 most essential questions first (as discussed above), then tackle the remaining questions for complete coverage. This feature helps you prioritize efficiently, solidifying core topics before moving on to more advanced or niche areas – a perfect antidote to feeling overwhelmed.
Past PLAB 1 candidates reviews about MedRevisions
How to use MedRevisions effectively for the PLAB 1 exam/ UKMLA exam preparation
Previous PLAB 1 or UKMLA exam guideline update
All MedRevisions recent updates
Check out this Neurology UKMLA / PLAB 1 exam-style question
Reference:
The Rheumatology Advances in Practice provides the scope of the British Society for Rheumatology guideline for the management of systemic sclerosis, which aims to provide a practical roadmap for management that builds upon the previous treatment guideline to incorporate advances in evidence-based treatment and increased knowledge about assessment, classification and management.
The White Rose Research Online provides a PDF version of the consensus best practice pathway for the management of cardiac disease in systemic sclerosis.
